Doctor of Pharmacy — 3.93/4.0
Silver Medallist · Summa Cum Laude
- Silver Medallist, Pharm.D (2019).
- Canadian equivalency established by PEBC: BSc in Pharmacy.
top of the batch, and the paperwork to prove it
In range · 4.4 °C · 2–8 °C
Someone has to account for every capsule.
I manage investigational medicinal product for clinical trials: the receipt, the fridge, the blind, the count, and the paperwork that has to survive a regulator reading it line by line. Twenty-plus trials, zero protocol deviations on product.
- 20+Trials with IMP
under my custody - 217Participants enrolled
on schedule - 7+DRAP reconciliation
panels led - 4International multicentre
trials led end to end
About
A hospital pharmacist who went and read the protocol.
I spent three years on the wards at Aga Khan University Hospital, ran the Emergency Department pharmacy team, and precepted ASHP PGY1 residents through their inpatient rotation. Then I moved into research, where the drug stops being routine and starts being evidence.
At AKU’s Clinical Trials Unit I’ve worked both sides of a study. In the research pharmacy I held IMP for more than twenty trials and answered for it to sponsors, monitors, JCIA surveyors, and DRAP. At the coordination desk I ran four international multicentre trials and a validation study from start-up to closeout, and chaired the unit’s Patient and Public Involvement and Engagement group.
Those two vantage points don’t usually sit in one person. Coordinators learn IMP as a checklist. Pharmacists learn the protocol as someone else’s problem. I’ve had to answer for both, which means I catch the gap between them before a monitor does.
I’m a Canadian permanent resident, open to roles anywhere in Canada, and glad to talk about research pharmacy, IMP management, and clinical trial operations.
IMP lifecycle
Six custody points. Each one is a place a trial can quietly fail.
-
01 · Receipt
The box meets the paperwork
Temperature on arrival, quantity against the manifest, seal and damage check. Nothing goes in the fridge until the shipment and the documentation agree.
-
02 · Storage
Hold the conditions
Cold chain at 2–8 °C or controlled room temperature, restricted access, calibrated loggers, continuous monitoring, and an excursion procedure people actually follow at 3am.
-
03 · Dispensing
Right kit, blind intact
IWRS/IRT assignment, label verification, participant counselling, and a blind that survives contact with a busy clinic.
-
04 · Accountability
Every unit has a name on it
Dispensed, returned, unused, damaged. Each one logged against a participant, a visit, and a date, in a record that reads the same six years later.
-
05 · Reconciliation
The monitor sees my numbers
Sponsor reconciliation and DRAP inspection panels work from the same count I do. No reconstruction, no surprises during closeout.
-
06 · Return
Close the chain
Return shipments or on-site destruction, certificates filed, custody documented from the manufacturer to the last unit.
Academic record
Education
The degrees behind the counts.
MBA, Health & Hospital Administration — 3.68/4.0
Health policy · Research methodology · Health ethics and law
- Core competencies in health policy, research and survey methodology, health ethics and law.
- Completed alongside full-time trial coordination: the management half of running studies.
PGY1 Pharmacy Residency (IPPR)
Inpatient practice residency
- Trainee Pharmacist of the Year, 2020.
- Later returned to the same rotation as preceptor-in-training.
PEBC equivalency
Employment record
Experience
Ward, then Research Pharmacy, then Trial Lead.
Senior Research Coordinator
The Aga Khan University
- Led four international multicentre trials plus a validation study, start-up to closeout.
- Opened new enrolment channels (advertising, community clinics, off-site physician referrals) reaching 217 participants on schedule.
- Led the unit’s Patient & Public Involvement and Engagement group, building its terms of reference and structural framework.
Research Coordinator
The Aga Khan University
- Ran timelines, deliverables, reporting and milestones for the PI’s studies, with CRF design, source data verification and real-time EDC entry to ALCOA+ standards.
- Quality reviews, internal audits, regulatory inspections: inspection-ready at all times, CAPAs closed.
- Also the unit’s marketing and communications lead: editor and design lead of the CTU newsletter, LinkedIn page and SharePoint site.
Research Pharmacist
The Aga Khan University
- IMP custody for 20+ trials, fully compliant with protocol, ICH-GCP, regulatory and JCIA requirements.
- Led 7+ DRAP reconciliation panels for international multicentre trials.
- Rewrote temperature-control policy; deviations dropped across the IMP lifecycle.
this is the one I’d put on the record first
Inpatient Pharmacist
Aga Khan University Hospital
- Emergency Department pharmacy team lead, with a Certificate of Appreciation for dedicated work in the ED, 2021.
- Built learning modules and precepted ASHP PGY1 residents on inpatient rotation.
Trainee Pharmacist
IPPR PGY1 (ASHP)
Intern Pharmacist
Oncology pharmacy operations
Six years, no gaps
Case record
Work
Five problems, and what I did about them.
The fridge kept drifting out of range
Recurring temperature deviations across the IMP lifecycle. I revised the governing policies rather than the individual logs: monitoring, thresholds, escalation, and who does what when the alarm sounds at 3am. Deviations fell and control held.
the printout that told the story
↓Deviations,
after revision
after revision
DRAP wanted the count reconciled
Led 7+ investigational product reconciliation panels with Pakistan’s drug regulator, records kept inspection-ready between panels rather than assembled the week before.
the count, reconciled
7+DRAP panels
led
led
A national summit needed running
Lead organizer of the Clinical Trials Summit of Pakistan 2025: marketing, registrations, audience engagement, and speaker and partner logistics.
a whole summit, start to finish
2025Clinical Trials Summit
of Pakistan
of Pakistan
Enrolment was going to miss the window
In-hospital referrals wouldn’t fill the studies. Added trial advertising, community-clinic referral pathways, and off-site physician referrals. 217 participants, on time.
three channels, one number
217Participants,
on time
on time
Participants had no route into study design
Led the CTU’s PPIE group, bringing patients and the public into planning rather than consulting them after the protocol was fixed.
a seat at the table, early
PPIEGroup lead,
AKU CTU
AKU CTU
Trial index, a selection
As coordinator
- STROKE
- OvaPrint
- KA6
As research pharmacist
- D-LIVR
- SUNRISE-3
- ACT-SouthAsia
- ACTION-III
- ESPRESSO
- HECOLIN
- AVT06
- EFFORT
- V201_03
- PREFER
Closeout
- PLATCOV
- A-PLUS
- FRACT-COV
- ACT
- DEFLECT
- CARES
- FURI
- + more
No findings on product
Certification register
Credentials
All current. All verifiable.
Certifications
- TCPS 2: CORE 2022 Panel on Research Ethics, Canada Completed 2026
- Certified Clinical Research Professional ACRP Issued Apr 2026
- GCP, Clinical Trials Involving Drugs CITI Program To 23 Jul 2028
- GCP, Clinical Trials Involving Devices CITI Program To 29 Jul 2028
- Basic Life Support, CPR & AED American Heart Association To 12 Sep 2027
- PEBC equivalency BSc Pharmacy, Canada Established
Recognition
- Silver Medallist, Pharm.D (2019) Dow University of Health Sciences 2019
- Trainee Pharmacist of the Year AKU Residency Program 2020
- Certificate of Appreciation Emergency Department 2021
- Certificate of Appreciation D-LIVR trial contribution 2023
- Trophy of Appreciation Malaria Elimination Consortium Symposium 2024
- Sustainability Champions Initiative nominee Aga Khan University 2024
EDC & trial systems
Analysis & tools
Practice
All dates current
Writing, editing, posters
Publications
In print and in progress.
Advancing National Clinical Trial Capacity: Key Initiatives by the Aga Khan University WHO Collaborating Centre
Pakistan Clinical Research Landscape 2026
- Co-authored with Dr. Saeed Hamid, Director of the Clinical Trials Unit, Aga Khan University.
- The chapter sets out the WHO Collaborating Centre’s capacity-building work, including the symposium on risk-based strategies across the clinical trial ecosystem run with the WHO and DRAP.
- Also named among the report’s acknowledged contributors.
Read the report PDF · 71 pages · 3.5MB
in print, and on the record
Chronic Therapy Medications During the Perioperative Period: To Continue or Discontinue?
Aga Khan University Hospital
The Research Continuum
CTU newsletter, Aga Khan University
- Founded the design and led content creation and publication of the unit’s recurring newsletter.
still my favourite side project
2023 onwards
Correspondence
Say Hello
If it involves research, I want to hear about it!
Research pharmacy roles, clinical trial operations, IMP consulting, or a question about getting a regulatory panel through. Email is fastest.
- Available in
- Canada
- Status
- Permanent residentConfirmed
- Available from
- September 2026Open
- Response
- Within 48 hours